<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33441">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01865019</url>
  </required_header>
  <id_info>
    <org_study_id>1981</org_study_id>
    <secondary_id>2013</secondary_id>
    <nct_id>NCT01865019</nct_id>
  </id_info>
  <brief_title>Pressure Controlled Versus Volume Controlled Mechanical Ventilation During Anesthesia for Living Donor Liver Transplantation Recipients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <authority>Egypt: faculty of medecine</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      pressure controlled ventilation will improve oxygenation indices , hemodynamics during
      anesthesia for living donor liver transplantation recipients ,improving postoperative graft
      function and decreasing postoperative pulmonary complications
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <target_duration>7 Days</target_duration>
  <primary_outcome>
    <measure>oxygen tension</measure>
    <time_frame>during intraoperative period</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>decreased postoperative pulmonary complications</measure>
    <time_frame>one week postoperative</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>improved intraoperative hemodynamics</measure>
    <time_frame>intraoperative</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Living Donor Liver Transplantation Recipients</condition>
  <arm_group>
    <arm_group_label>volume controlled</arm_group_label>
    <description>volume ontrolled ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pressure controlled</arm_group_label>
    <description>pressure controlled ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>mechanical ventilation</intervention_name>
    <arm_group_label>volume controlled</arm_group_label>
    <arm_group_label>pressure controlled</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        living donor liver transplantation recipients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all living donor liver transplantation recipients scheduled

        Exclusion Criteria:

          -  Moderate to severe restrictive pulmonary functions
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gastroenterology center</name>
      <address>
        <city>Mansoura</city>
        <state>Dakahleya</state>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amr M Yassen, Professor</last_name>
      <phone>01001497044</phone>
      <phone_ext>002</phone_ext>
      <email>amryassen@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Al-refaey a KANDEEL, MASTER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 26, 2013</lastchanged_date>
  <firstreceived_date>April 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Amr Mohamed Yassen</investigator_full_name>
    <investigator_title>PROFESSOR</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
